Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CV 2619

Known as: CV-2619 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
In this study, we examined the effect of the neuroprotective agent 2, 3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone… Expand
Is this relevant?
1985
1985
The effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in isolated brain… Expand
Is this relevant?
1985
1985
The effects of 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (CV-2619) on the respiration and non-respiratory… Expand
Is this relevant?
1985
1985
After oral administration of 14C-labeled idebenone (14C-CV-2619) to rats, the plasma 14C level reached a plateau at 15 min, which… Expand
Is this relevant?
1984
1984
Lipid peroxidation in rat brain mitochondria was induced by NADH in the presence of ADP and FeCl3. CV-2619 inhibited the lipid… Expand
Is this relevant?
1984
1984
(A. Nagaoka et al., unpublished data). In the present study, we examined the effects of CV-2619 on lipid peroxidation in brain… Expand
Is this relevant?
1984
1984
The concentrations of acetylcholine (Ach) and choline in various brain regions of rats with and without cerebral ischemia and the… Expand
Is this relevant?
1984
1984
An experimental model of amnesia induced by cerebral ischemia after one-trial passive avoidance learning was established to test… Expand
Is this relevant?
1984
1984
The effects of a novel compound, 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone (idebenone, CV-2619), on cerebral… Expand
Is this relevant?
1984
1984
Improvement of energy metabolism in ischemic cerebral tissue benefits the therapy of occlusive cerebrovascular lesions. In the… Expand
Is this relevant?